MicroRNA-185 suppresses proliferation, invasion, migration, and tumorigenicity of human prostate cancer cells through targeting androgen receptor
Previous studies have shown that androgen receptor (AR) is involved in the progression of prostate cancer (CaP) by several mechanisms. However, how AR is regulated has not been fully understood. In this study, miR-185 was found to be down-regulated in clinical CaP samples. Targets prediction reveale...
Gespeichert in:
Veröffentlicht in: | Molecular and cellular biochemistry 2013-05, Vol.377 (1-2), p.121-130 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 130 |
---|---|
container_issue | 1-2 |
container_start_page | 121 |
container_title | Molecular and cellular biochemistry |
container_volume | 377 |
creator | Qu, Fajun Cui, Xingang Hong, Yi Wang, Junkai Li, Yao Chen, Lu Liu, Yushan Gao, Yi Xu, Danfeng Wang, Quanxing |
description | Previous studies have shown that androgen receptor (AR) is involved in the progression of prostate cancer (CaP) by several mechanisms. However, how AR is regulated has not been fully understood. In this study, miR-185 was found to be down-regulated in clinical CaP samples. Targets prediction revealed that AR had putative complementary sequences to miR-185, which was confirmed by the following dual luciferase reporter assay. Overexpression of miR-185 could reduce the expression of AR protein but not mRNA in LNCaP cells. The proliferation of LNCaP cells was inhibited by overexpression of miR-185. Cell cycle analysis revealed cell cycle arrest at G0/G1 phase. The invasive and migration abilities of cells could also be suppressed by miR-185. Furthermore, miR-185 inhibited tumorigenicity in a CaP xenografts model. CDC6, one target of AR and an important regulatory molecule for cell cycle, was found to be down-regulated by overexpression of miR-185. Our findings suggest that miR-185 could function as a tumor-suppressor gene in CaP by directly targeting AR, and act as a potential therapeutic target for CaP. |
doi_str_mv | 10.1007/s11010-013-1576-z |
format | Article |
fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_journals_1364560176</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A336177131</galeid><sourcerecordid>A336177131</sourcerecordid><originalsourceid>FETCH-LOGICAL-c539t-a0bb5accdc1a272a9b1e288513956d787ce811b435f1eb2f9f3b030cdbbe3b763</originalsourceid><addsrcrecordid>eNqNUtGK1DAULaK44-oH-CIBX-2a2zRN-zgsuiusCqLPIUlvO1napCapsPsX_rEZZ1dGUJE85HJzzrnh3FMUz4GeAaXidQSgQEsKrAQumvL2QbHJBSvrDrqHxYYySssWhDgpnsR4TTOYAjwuTipWg6jqalN8f29N8J8-bEtoOYnrsgSMESNZgp_sgEEl690rYt03FX9Wsx3vm8r1JK2zD3ZEZ41NN8QPZLfOyu35MamExChnMBCD0xRJ2gW_jjuSVBgxWTfuNYLPdBLQ4JJ8eFo8GtQU8dndfVp8efvm8_llefXx4t359qo0nHWpVFRrrozpDahKVKrTgFXbcmAdb3rRCoMtgK4ZHwB1NXQD09kP02uNTIuGnRYvD7r5p19XjEle-zW4PFICa2reUDhGjWpCad3gU1BmttHIbV13XAjg_J8oxpq8AWCQUWd_QOXT42yNdzjY3P9N9r8IxxPgQMg7jTHgIJdgZxVuJFC5j4w8REbmyMh9ZORt5ry482HVM_a_GPcZyYDqAIj5yY0Yjoz6q-oP5bvMZA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1364560176</pqid></control><display><type>article</type><title>MicroRNA-185 suppresses proliferation, invasion, migration, and tumorigenicity of human prostate cancer cells through targeting androgen receptor</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><creator>Qu, Fajun ; Cui, Xingang ; Hong, Yi ; Wang, Junkai ; Li, Yao ; Chen, Lu ; Liu, Yushan ; Gao, Yi ; Xu, Danfeng ; Wang, Quanxing</creator><creatorcontrib>Qu, Fajun ; Cui, Xingang ; Hong, Yi ; Wang, Junkai ; Li, Yao ; Chen, Lu ; Liu, Yushan ; Gao, Yi ; Xu, Danfeng ; Wang, Quanxing</creatorcontrib><description>Previous studies have shown that androgen receptor (AR) is involved in the progression of prostate cancer (CaP) by several mechanisms. However, how AR is regulated has not been fully understood. In this study, miR-185 was found to be down-regulated in clinical CaP samples. Targets prediction revealed that AR had putative complementary sequences to miR-185, which was confirmed by the following dual luciferase reporter assay. Overexpression of miR-185 could reduce the expression of AR protein but not mRNA in LNCaP cells. The proliferation of LNCaP cells was inhibited by overexpression of miR-185. Cell cycle analysis revealed cell cycle arrest at G0/G1 phase. The invasive and migration abilities of cells could also be suppressed by miR-185. Furthermore, miR-185 inhibited tumorigenicity in a CaP xenografts model. CDC6, one target of AR and an important regulatory molecule for cell cycle, was found to be down-regulated by overexpression of miR-185. Our findings suggest that miR-185 could function as a tumor-suppressor gene in CaP by directly targeting AR, and act as a potential therapeutic target for CaP.</description><identifier>ISSN: 0300-8177</identifier><identifier>EISSN: 1573-4919</identifier><identifier>DOI: 10.1007/s11010-013-1576-z</identifier><identifier>PMID: 23417242</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Analysis ; Androgens ; Animals ; Base Sequence ; Binding Sites ; Biochemistry ; Biomedical and Life Sciences ; Cardiology ; Cell adhesion & migration ; Cell Cycle Proteins - genetics ; Cell Cycle Proteins - metabolism ; Cell growth ; Cell Line, Tumor ; Cell Movement ; Cell Proliferation ; Cell Transformation, Neoplastic - metabolism ; Development and progression ; G1 Phase Cell Cycle Checkpoints ; Gene Expression ; Gene Expression Regulation, Neoplastic ; Health aspects ; HEK293 Cells ; Humans ; Life Sciences ; Luciferase ; Male ; Medical Biochemistry ; Mice ; Mice, Inbred BALB C ; Mice, Nude ; MicroRNA ; MicroRNAs - genetics ; MicroRNAs - metabolism ; Neoplasm Invasiveness ; Neoplasm Transplantation ; Nuclear Proteins - genetics ; Nuclear Proteins - metabolism ; Oncology ; Prostate cancer ; Prostatic Neoplasms - metabolism ; Prostatic Neoplasms - pathology ; Receptors, Androgen - genetics ; Receptors, Androgen - metabolism ; Ribonucleic acid ; RNA ; RNA Interference ; RNA, Messenger - genetics ; RNA, Messenger - metabolism ; Tumor Burden</subject><ispartof>Molecular and cellular biochemistry, 2013-05, Vol.377 (1-2), p.121-130</ispartof><rights>Springer Science+Business Media New York 2013</rights><rights>COPYRIGHT 2013 Springer</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c539t-a0bb5accdc1a272a9b1e288513956d787ce811b435f1eb2f9f3b030cdbbe3b763</citedby><cites>FETCH-LOGICAL-c539t-a0bb5accdc1a272a9b1e288513956d787ce811b435f1eb2f9f3b030cdbbe3b763</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s11010-013-1576-z$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s11010-013-1576-z$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,777,781,27905,27906,41469,42538,51300</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23417242$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Qu, Fajun</creatorcontrib><creatorcontrib>Cui, Xingang</creatorcontrib><creatorcontrib>Hong, Yi</creatorcontrib><creatorcontrib>Wang, Junkai</creatorcontrib><creatorcontrib>Li, Yao</creatorcontrib><creatorcontrib>Chen, Lu</creatorcontrib><creatorcontrib>Liu, Yushan</creatorcontrib><creatorcontrib>Gao, Yi</creatorcontrib><creatorcontrib>Xu, Danfeng</creatorcontrib><creatorcontrib>Wang, Quanxing</creatorcontrib><title>MicroRNA-185 suppresses proliferation, invasion, migration, and tumorigenicity of human prostate cancer cells through targeting androgen receptor</title><title>Molecular and cellular biochemistry</title><addtitle>Mol Cell Biochem</addtitle><addtitle>Mol Cell Biochem</addtitle><description>Previous studies have shown that androgen receptor (AR) is involved in the progression of prostate cancer (CaP) by several mechanisms. However, how AR is regulated has not been fully understood. In this study, miR-185 was found to be down-regulated in clinical CaP samples. Targets prediction revealed that AR had putative complementary sequences to miR-185, which was confirmed by the following dual luciferase reporter assay. Overexpression of miR-185 could reduce the expression of AR protein but not mRNA in LNCaP cells. The proliferation of LNCaP cells was inhibited by overexpression of miR-185. Cell cycle analysis revealed cell cycle arrest at G0/G1 phase. The invasive and migration abilities of cells could also be suppressed by miR-185. Furthermore, miR-185 inhibited tumorigenicity in a CaP xenografts model. CDC6, one target of AR and an important regulatory molecule for cell cycle, was found to be down-regulated by overexpression of miR-185. Our findings suggest that miR-185 could function as a tumor-suppressor gene in CaP by directly targeting AR, and act as a potential therapeutic target for CaP.</description><subject>Analysis</subject><subject>Androgens</subject><subject>Animals</subject><subject>Base Sequence</subject><subject>Binding Sites</subject><subject>Biochemistry</subject><subject>Biomedical and Life Sciences</subject><subject>Cardiology</subject><subject>Cell adhesion & migration</subject><subject>Cell Cycle Proteins - genetics</subject><subject>Cell Cycle Proteins - metabolism</subject><subject>Cell growth</subject><subject>Cell Line, Tumor</subject><subject>Cell Movement</subject><subject>Cell Proliferation</subject><subject>Cell Transformation, Neoplastic - metabolism</subject><subject>Development and progression</subject><subject>G1 Phase Cell Cycle Checkpoints</subject><subject>Gene Expression</subject><subject>Gene Expression Regulation, Neoplastic</subject><subject>Health aspects</subject><subject>HEK293 Cells</subject><subject>Humans</subject><subject>Life Sciences</subject><subject>Luciferase</subject><subject>Male</subject><subject>Medical Biochemistry</subject><subject>Mice</subject><subject>Mice, Inbred BALB C</subject><subject>Mice, Nude</subject><subject>MicroRNA</subject><subject>MicroRNAs - genetics</subject><subject>MicroRNAs - metabolism</subject><subject>Neoplasm Invasiveness</subject><subject>Neoplasm Transplantation</subject><subject>Nuclear Proteins - genetics</subject><subject>Nuclear Proteins - metabolism</subject><subject>Oncology</subject><subject>Prostate cancer</subject><subject>Prostatic Neoplasms - metabolism</subject><subject>Prostatic Neoplasms - pathology</subject><subject>Receptors, Androgen - genetics</subject><subject>Receptors, Androgen - metabolism</subject><subject>Ribonucleic acid</subject><subject>RNA</subject><subject>RNA Interference</subject><subject>RNA, Messenger - genetics</subject><subject>RNA, Messenger - metabolism</subject><subject>Tumor Burden</subject><issn>0300-8177</issn><issn>1573-4919</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqNUtGK1DAULaK44-oH-CIBX-2a2zRN-zgsuiusCqLPIUlvO1napCapsPsX_rEZZ1dGUJE85HJzzrnh3FMUz4GeAaXidQSgQEsKrAQumvL2QbHJBSvrDrqHxYYySssWhDgpnsR4TTOYAjwuTipWg6jqalN8f29N8J8-bEtoOYnrsgSMESNZgp_sgEEl690rYt03FX9Wsx3vm8r1JK2zD3ZEZ41NN8QPZLfOyu35MamExChnMBCD0xRJ2gW_jjuSVBgxWTfuNYLPdBLQ4JJ8eFo8GtQU8dndfVp8efvm8_llefXx4t359qo0nHWpVFRrrozpDahKVKrTgFXbcmAdb3rRCoMtgK4ZHwB1NXQD09kP02uNTIuGnRYvD7r5p19XjEle-zW4PFICa2reUDhGjWpCad3gU1BmttHIbV13XAjg_J8oxpq8AWCQUWd_QOXT42yNdzjY3P9N9r8IxxPgQMg7jTHgIJdgZxVuJFC5j4w8REbmyMh9ZORt5ry482HVM_a_GPcZyYDqAIj5yY0Yjoz6q-oP5bvMZA</recordid><startdate>20130501</startdate><enddate>20130501</enddate><creator>Qu, Fajun</creator><creator>Cui, Xingang</creator><creator>Hong, Yi</creator><creator>Wang, Junkai</creator><creator>Li, Yao</creator><creator>Chen, Lu</creator><creator>Liu, Yushan</creator><creator>Gao, Yi</creator><creator>Xu, Danfeng</creator><creator>Wang, Quanxing</creator><general>Springer US</general><general>Springer</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7QP</scope><scope>7T5</scope><scope>7T7</scope><scope>7TK</scope><scope>7TM</scope><scope>7TO</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>88I</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7N</scope><scope>M7P</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>RC3</scope></search><sort><creationdate>20130501</creationdate><title>MicroRNA-185 suppresses proliferation, invasion, migration, and tumorigenicity of human prostate cancer cells through targeting androgen receptor</title><author>Qu, Fajun ; Cui, Xingang ; Hong, Yi ; Wang, Junkai ; Li, Yao ; Chen, Lu ; Liu, Yushan ; Gao, Yi ; Xu, Danfeng ; Wang, Quanxing</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c539t-a0bb5accdc1a272a9b1e288513956d787ce811b435f1eb2f9f3b030cdbbe3b763</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Analysis</topic><topic>Androgens</topic><topic>Animals</topic><topic>Base Sequence</topic><topic>Binding Sites</topic><topic>Biochemistry</topic><topic>Biomedical and Life Sciences</topic><topic>Cardiology</topic><topic>Cell adhesion & migration</topic><topic>Cell Cycle Proteins - genetics</topic><topic>Cell Cycle Proteins - metabolism</topic><topic>Cell growth</topic><topic>Cell Line, Tumor</topic><topic>Cell Movement</topic><topic>Cell Proliferation</topic><topic>Cell Transformation, Neoplastic - metabolism</topic><topic>Development and progression</topic><topic>G1 Phase Cell Cycle Checkpoints</topic><topic>Gene Expression</topic><topic>Gene Expression Regulation, Neoplastic</topic><topic>Health aspects</topic><topic>HEK293 Cells</topic><topic>Humans</topic><topic>Life Sciences</topic><topic>Luciferase</topic><topic>Male</topic><topic>Medical Biochemistry</topic><topic>Mice</topic><topic>Mice, Inbred BALB C</topic><topic>Mice, Nude</topic><topic>MicroRNA</topic><topic>MicroRNAs - genetics</topic><topic>MicroRNAs - metabolism</topic><topic>Neoplasm Invasiveness</topic><topic>Neoplasm Transplantation</topic><topic>Nuclear Proteins - genetics</topic><topic>Nuclear Proteins - metabolism</topic><topic>Oncology</topic><topic>Prostate cancer</topic><topic>Prostatic Neoplasms - metabolism</topic><topic>Prostatic Neoplasms - pathology</topic><topic>Receptors, Androgen - genetics</topic><topic>Receptors, Androgen - metabolism</topic><topic>Ribonucleic acid</topic><topic>RNA</topic><topic>RNA Interference</topic><topic>RNA, Messenger - genetics</topic><topic>RNA, Messenger - metabolism</topic><topic>Tumor Burden</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Qu, Fajun</creatorcontrib><creatorcontrib>Cui, Xingang</creatorcontrib><creatorcontrib>Hong, Yi</creatorcontrib><creatorcontrib>Wang, Junkai</creatorcontrib><creatorcontrib>Li, Yao</creatorcontrib><creatorcontrib>Chen, Lu</creatorcontrib><creatorcontrib>Liu, Yushan</creatorcontrib><creatorcontrib>Gao, Yi</creatorcontrib><creatorcontrib>Xu, Danfeng</creatorcontrib><creatorcontrib>Wang, Quanxing</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Immunology Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>Genetics Abstracts</collection><jtitle>Molecular and cellular biochemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Qu, Fajun</au><au>Cui, Xingang</au><au>Hong, Yi</au><au>Wang, Junkai</au><au>Li, Yao</au><au>Chen, Lu</au><au>Liu, Yushan</au><au>Gao, Yi</au><au>Xu, Danfeng</au><au>Wang, Quanxing</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>MicroRNA-185 suppresses proliferation, invasion, migration, and tumorigenicity of human prostate cancer cells through targeting androgen receptor</atitle><jtitle>Molecular and cellular biochemistry</jtitle><stitle>Mol Cell Biochem</stitle><addtitle>Mol Cell Biochem</addtitle><date>2013-05-01</date><risdate>2013</risdate><volume>377</volume><issue>1-2</issue><spage>121</spage><epage>130</epage><pages>121-130</pages><issn>0300-8177</issn><eissn>1573-4919</eissn><abstract>Previous studies have shown that androgen receptor (AR) is involved in the progression of prostate cancer (CaP) by several mechanisms. However, how AR is regulated has not been fully understood. In this study, miR-185 was found to be down-regulated in clinical CaP samples. Targets prediction revealed that AR had putative complementary sequences to miR-185, which was confirmed by the following dual luciferase reporter assay. Overexpression of miR-185 could reduce the expression of AR protein but not mRNA in LNCaP cells. The proliferation of LNCaP cells was inhibited by overexpression of miR-185. Cell cycle analysis revealed cell cycle arrest at G0/G1 phase. The invasive and migration abilities of cells could also be suppressed by miR-185. Furthermore, miR-185 inhibited tumorigenicity in a CaP xenografts model. CDC6, one target of AR and an important regulatory molecule for cell cycle, was found to be down-regulated by overexpression of miR-185. Our findings suggest that miR-185 could function as a tumor-suppressor gene in CaP by directly targeting AR, and act as a potential therapeutic target for CaP.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>23417242</pmid><doi>10.1007/s11010-013-1576-z</doi><tpages>10</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0300-8177 |
ispartof | Molecular and cellular biochemistry, 2013-05, Vol.377 (1-2), p.121-130 |
issn | 0300-8177 1573-4919 |
language | eng |
recordid | cdi_proquest_journals_1364560176 |
source | MEDLINE; Springer Nature - Complete Springer Journals |
subjects | Analysis Androgens Animals Base Sequence Binding Sites Biochemistry Biomedical and Life Sciences Cardiology Cell adhesion & migration Cell Cycle Proteins - genetics Cell Cycle Proteins - metabolism Cell growth Cell Line, Tumor Cell Movement Cell Proliferation Cell Transformation, Neoplastic - metabolism Development and progression G1 Phase Cell Cycle Checkpoints Gene Expression Gene Expression Regulation, Neoplastic Health aspects HEK293 Cells Humans Life Sciences Luciferase Male Medical Biochemistry Mice Mice, Inbred BALB C Mice, Nude MicroRNA MicroRNAs - genetics MicroRNAs - metabolism Neoplasm Invasiveness Neoplasm Transplantation Nuclear Proteins - genetics Nuclear Proteins - metabolism Oncology Prostate cancer Prostatic Neoplasms - metabolism Prostatic Neoplasms - pathology Receptors, Androgen - genetics Receptors, Androgen - metabolism Ribonucleic acid RNA RNA Interference RNA, Messenger - genetics RNA, Messenger - metabolism Tumor Burden |
title | MicroRNA-185 suppresses proliferation, invasion, migration, and tumorigenicity of human prostate cancer cells through targeting androgen receptor |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T19%3A20%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=MicroRNA-185%20suppresses%20proliferation,%20invasion,%20migration,%20and%20tumorigenicity%20of%20human%20prostate%20cancer%20cells%20through%20targeting%20androgen%20receptor&rft.jtitle=Molecular%20and%20cellular%20biochemistry&rft.au=Qu,%20Fajun&rft.date=2013-05-01&rft.volume=377&rft.issue=1-2&rft.spage=121&rft.epage=130&rft.pages=121-130&rft.issn=0300-8177&rft.eissn=1573-4919&rft_id=info:doi/10.1007/s11010-013-1576-z&rft_dat=%3Cgale_proqu%3EA336177131%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1364560176&rft_id=info:pmid/23417242&rft_galeid=A336177131&rfr_iscdi=true |